European Archives - Page 206 of 1272 - European Medical Journal

Breakthrough CRISPR Test Detects Pathogens in Minutes

The new CRISPR-Cascade assay eliminates the need for nucleic acid amplification, enabling highly sensitive detection of pathogens within minutes.

Children Face Higher Risk of Long-Term Gastrointestinal Issues After COVID-19

A new study found that children with COVID-19 have a 25% higher risk of developing persistent gastrointestinal symptoms months after infection.

New Endometriosis Pill New Hope for Patients

With the approval of Ryeqo, endometriosis patients in the UK will benefit from a treatment that enhances convenience and autonomy.

Heated Lidocaine Gel Could Reduce Pain in Transrectal Ultrasound-Guided Prostate Biopsy

A new study suggests heated lidocaine gel combined with periprostatic nerve block reduces pain during prostate biopsy without increasing complications.

Red Versus White Wine: A Difference in Cancer Risk?

A new meta-analysis challenges the widely held belief that red wine is a healthier alternative to other alcoholic beverages.

Yttrium-90 Transarterial Radioembolisation may Prolong Survival with Hepatocellular Carcinoma

Yttrium-90 radioembolisation may offer improved survival for large hepatocellular carcinoma tumours compared to transarterial hepatic embolisation.

Vitamin D Significantly Reduces MS Disease Activity, Landmark Trial Shows

High-dose vitamin D delays MS progression by 200 days in early-stage patients. MRI data shows significant benefits.

Impact of Multihit TP53 Mutations on Myeloproliferative Disorders

A new study accessed the Mayo Clinic database to investigate the long-term survival of patients with myeloproliferative neoplasms and acute myeloid leukaemia associated with multihit TP53 mutations…

EAU 2025 – Sensory T-Shirt Technology Transforms Recovery After Urological Cancer Surgery

Smart t-shirt enables earlier discharge after urological cancer surgery, improving patient comfort and reducing hospital stays.

Type 2 Diabetes Remission from Novel Treatment Combination

New research has investigated how a combination of dapagliflozin and moderate calorie restriction can cause remission in Type 2 diabetes